Management of Cardiac Involvement in NeuroMuscular Diseases: Review

Rachida Bouhouch*, Tarik Elhouari, Latifa Oukerraj, Ibtissam Fellat, Jamila Zarzur, Rajaa Bennani, Mhamed Arharbi
Service de Cardiologie B, CHU Ibn Sina Rabat, MAROC

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 1071
Abstract HTML Views: 464
PDF Downloads: 328
Total Views/Downloads: 1863
Unique Statistics:

Full-Text HTML Views: 414
Abstract HTML Views: 297
PDF Downloads: 236
Total Views/Downloads: 947

Creative Commons License
© Bouhouch et al.; Licensee Bentham Open.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.

* Address correspondence to this author at the Service de Cardiologie B, CHU Ibn Sina Rabat, MAROC; E-mail:


Neuromuscular Diseases are a heterogeneous molecular, clinical and prognosis group. Progress has been achieved in the understanding and classification of these diseases.

Cardiac involvement in neuromuscular diseases namely conduction disorders, ventricular dilatation and dilated cardiomyopathy with its impact on prognosis, is often dissociated from the peripheral myopathy. Therefore, close surveillance is mandatory in the affected patients. In this context, preventive therapy (beta-blockers and angiotensin converting enzyme inhibitors) has been recently recommended in the most common Neuromuscular Diseases, Duchenne Muscular Dystrophy and Myotonic Dystrophy.

Key Words: Muscular dystrophy, cardiomyopathy, sudden cardiac death..